Commit To Buy Zynerba Pharmaceuticals At $10, Earn 27.7% Annualized Using Options
January 18, 2018 at 11:59 AM EST
Investors eyeing a purchase of Zynerba Pharmaceuticals Inc (ZYNE) stock, but cautious about paying the going market price of $11.73/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $10 strike, which has a bid at the time of this writing of $1.60..